SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Discussion centers on Lillys obesity and diabetes franchise and expectations for quarterly results, with traders pointing to Mounjaro and Zepbound demand, Foundayo uptake, and pipeline prospects. Bulls cite growth and healthcare-sector strength, while skeptics flag Lillys high valuation and competition from Novo Nordisk and emerging obesity-drug rivals.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, driven by weak demand, excess distributor inventory and a major pricing reset, has intensified concerns about its business and heavy debt. Traders are divided between viewing the reset and debt-reduction measures as a path to recovery and fearing further deterioration or bankruptcy.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Discussion centers on whether Teladoc can show a credible turnaround in its quarterly results, especially stabilizing BetterHelp as it shifts from cash-pay to insurance amid concerns about declining revenue, profitability and management execution. Bulls cite potential insurance growth, Teladoc One and short-interest dynamics, while skeptics remain doubtful; squeeze claims are speculative.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens attention is centered on Phase 3 results showing IMDELLTRA with AstraZenecas IMFINZI reduced the risk of death in first-line extensive-stage small-cell lung cancer. Traders are treating the survival findings as a positive oncology catalyst, while some also point to favorable Phase 3 TEZSPIRE results in eosinophilic esophagitis.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a recurring topic, with traders pointing to alleged executive connections and J&Js oncology ambitions; no deal has been confirmed. Traders are also debating J&Js earnings reaction: stronger-than-expected results and raised guidance were offset by weak MedTech growth and litigation concerns, while some view the pullback as a buying opportunity.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas oncology and rare-disease pipeline is drawing attention, with traders highlighting the U.S. launch of lung-cancer drug Zegfrovy, an accelerated FDA approval for Ultomiris in IgA nephropathy, and positive trial updates. Reactions are mixed between optimism about new treatment opportunities and concern about recent trial setbacks and share-price weakness.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to record highs is drawing attention as firm crude prices and Middle East supply concerns support energy stocks, with traders also positioning ahead of the companys earnings report. Sentiment is largely bullish around the momentum, though some caution that the rally is extended and the results could test whether it can hold.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

The ongoing shale-oil antitrust case is drawing attention after the judge deferred jurisdictional rulings for Hess and Pioneer pending limited discovery, with an October status conference ahead; traders emphasize that the claims remain unresolved. Bullish chatter also points to oil-linked strength and a possible technical breakout, though some traders are watching resistance.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is drawing attention around GameStops nearly 10% stake and its rejected takeover bid, with traders debating whether GameStop will renew its acquisition push, seek a partnership or board influence, or step back. Speculation is tempered by doubts about financing and deal merits, while some traders also cite eBays earnings and analyst support.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is drawing attention amid volatile crude prices and Middle East supply concerns, especially reports involving Iran and Strait of Hormuz shipping. Traders are bullish on the potential benefit to producers but debate why energy shares often lag oil, while ceasefire and deal speculation has raised concerns that the geopolitical risk premium could fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PLTR Stock Garners Retail Attention On AI Infrastructure Deals At Davos

Equity

Palantir partnered with UK-based AI firm Sovereign AI (S-AI) and Accenture to build next-generation sovereign AI data centres across Europe, the Middle East, and Africa, with plans to expand into Asia-Pacific.

Tidal Trust II - YieldMax PLTR Option Income Strategy ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Palantir also strengthened its alliance with HD Hyundai in a deal reportedly worth ‘‘hundreds of millions of dollars”.</li><li>Both agreements were signed at the World Economic Forum (WEF) meeting in Davos, Switzerland.</li><li>CEO Alex Karp reportedly said Palantir remains firmly focused on the U.S. market and does not consider international corporate sales as a major priority.</li></ul>Palantir Technologies Inc. (PLTR) garnered retail buzz on Wednesday, driven by a series of partnerships to advance AI-based infrastructure.The stock slid 0.2% in pre-market trading on Wednesday, with <a href="https://stocktwits.com/symbol/PLTR">PLTR</a> among the top trending tickers on Stocktwits at the time of writing.Over the past 24 hours, message volumes on PLTR increased more than 200%, according to Stocktwits data. &nbsp;<h2 class="st-heading-2">Partnerships with S-AI and HD Hyundai</h2>Palantir tied up with UK-based AI firm Sovereign AI (S-AI) and Accenture to build next-generation sovereign AI data centers across Europe, the Middle East, and Africa, with plans to expand into Asia-Pacific. The collaboration will support the rollout of Dell AI Factory and NVIDIA-powered data centers designed to handle high-intensity AI workloads.Palantir’s Chain Reaction platform will help develop the full infrastructure lifecycle, from power generation to compute deployment, while Accenture will handle digital transformation, operations, and delivery.Prior to that, Palantir strengthened its alliance with HD Hyundai, its largest and longest-running partnership in South Korea. The partnership broadens the use of Palantir’s Foundry and AI Platform across shipbuilding, energy, construction equipment, robotics, and marine services. The partners also plan to establish a Center of Excellence to drive AI adoption across the HD Hyundai Group.According to a Reuters report on Tuesday, the HD Hyundai deal is worth ‘hundreds of millions of dollars’ to Palantir over several years.Both agreements were signed at the World Economic Forum (WEF) meeting in Davos, Switzerland.Speaking on the sidelines of the event, CEO Alex Karp reportedly said Palantir remains firmly focused on the U.S. market, adding that, outside of Korea, international corporate sales are not a major priority for the company."We're doing so well in America, we have to selectively engage abroad,” he said.<h2 class="st-heading-2">What Are Analysts Saying?</h2>Last week, Citi upgraded Palantir to ‘Buy from ‘Neutral’ and raised its price target to $235, citing expectations for significantly higher consensus estimates in 2026, according to The Fly. The firm sees accelerating enterprise adoption and rising defense budgets as key drivers, describing a potential “supercycle” for Palantir’s government business and forecasting a 70%-80% revenue growth in 2026.&nbsp;Separately, Truist initiated coverage with a ‘Buy’ rating and a $223 price target. Truist highlighted Palantir’s unique market position and strong exposure to AI adoption across both government and enterprise customers. The firm also expects Palantir to maintain healthy margins while benefiting from AI-driven revenue growth.<h2 class="st-heading-2">What Is Retail Saying?</h2>Sentiment on Stocktwits changed to ‘neutral’ from ‘bearish’ a day earlier.One user noted the stock breaking to the downside.<stembedurl>https://stocktwits.com/peloswing/message/642346837</stembedurl>Another bearish user saw the stock as overvalued.<stembedurl>https://stocktwits.com/GRTiVST/message/642384227</stembedurl>The stock has gained over 130% in the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-avr-stock-surge-pre-market-today/cmUDFTBR4fG">Why Did AVR Stock Surge Pre-Market Today?&nbsp;</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Palantir logo is displayed on a mobile phone with a financial stock graph seen in the background, in this photo illustration in Brussels, Belgium, on November 3, 2025.

REX AI Equity Premium Income ETF

iShares US Tech Independence Focused ETF

Palantir Technologies Inc

YieldMax PLTR Option Income Strategy ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

PLTY YieldMax PLTR Option Income Strategy ETF

Fundamentals

Latest PLTY News